Digital Diagnostics is so grateful to have been part of the meaningful conversations at the 2025 OCHIN Learning Forum!
An annual event, the OCHIN Learning Forum brings together healthcare professionals to explore methods, workflows, and techniques needed to increase patient engagement, reduce administrative and clinical burden, and improve whole patient care delivery.
Our team participated in several ways, including exhibiting at booth #105, where company representatives were on hand to demonstrate how LumineticsCore®, our AI diagnostic solution for diabetic retinopathy (DR), can help improve care gap closure rates for the eye exam for diabetes at the point-of-care.
During the event, the 1,100+ attendees had access to over 160 sessions – one of which was co-hosted by Kurt Blasena, Digital Diagnostics’ Chief Commercial Officer, and Jeff Jarboe, Product Engineer at OCHIN. Their session, AI to Diagnose Diabetic Retinopathy, highlighted the benefits of LumineticsCore, including early DR detection, point-of-care diagnostic results, no need for physician overread, and medical liability being held by the AI creator for medical decisions made by AI.
The presentation also featured a case study on our customer, Tarzana Treatment Centers (TTC). Dr. Christian Espinoza, Director of Clinic Operations at TTC,
As a healthcare technology company committed to transforming healthcare through AI, we are honored to partner with OCHIN, one of the largest health information networks in the U.S., as well as collaborate with innovative organizations like TTC.
Want to learn more about TTC’s implementation of LumineticsCore? Check out this comprehensive white paper.